Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.

Slides:



Advertisements
Similar presentations
Analysis of High-Throughput Screening Data C371 Fall 2004.
Advertisements

211 PHC By: Dr. Reem Al-Wabli Dr. Ebtehal Al-Abdullah Dr. Maha Al-Mutairi.
1 Sequential Screening S. Stanley Young NISS HTS Workshop October 25, 2002.
3D Molecular Structures C371 Fall Morgan Algorithm (Leach & Gillet, p. 8)
In silico small molecule discovery Sales Target gene Discover hit Hit to lead Optimise lead Clinical Target gene identified with a viable assay High throughput.
PharmaMiner: Geometric Mining of Pharmacophores 1.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Lipinski’s rule of five
1 PharmID: A New Algorithm for Pharmacophore Identification Stan Young Jun Feng and Ashish Sanil NISSMPDM 3 June 2005.
Cheminformatics II Apr 2010 Postgrad course on Comp Chem Noel M. O’Boyle.
S TRUCTURAL B IOINFORMATICS. A subset of Bioinformatics concerned with the of biological structures - proteins, DNA, RNA, ligands etc. It is the first.
Drug Design Dr. Bilal Al-Jaidi.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
1CBS, Department of Systems Biology Exercise : Drug-likeness by ’rule of five’ Log into your databar account, start Firefox and go to the following web-
M. Wagener 3D Database Searching and Scaffold Hopping Markus Wagener NV Organon.
Design of Small Molecule Drugs Targeted to RNA RNA Ontology Group May
Structural biology and drug design: An overview Olivier Taboureau Assitant professor Chemoinformatics group-CBS-DTU
In Silico Design of Selective Estrogen Receptor Modulators from Triazoles and Imines Joey Salisbury Dr. John C. Williams Small Molecules/Large Molecules.
Chemoinformatics in Drug Design
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Drug Development
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
Structure-based Drug Design
Chapter 9: Making new antibiotics. Model organisms are used to speed drug discovery A model organism is a non-human species that is extensively studied.
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
Drug discovery and development
Lecture 7: Computer aided drug design: Statistical approach. Lecture 7: Computer aided drug design: Statistical approach. Chen Yu Zong Department of Computational.
GGAGATTCTGGGCCACTTTGGTTCCCCATGAGCCAAGACGGCACTTCTAATTTGCATTCCCTACCGGAGTCCCTGTCTGTAGCCAGCCTGGCTTTCAGCTGGTGCCCAAAGTGACAAATGTATCTGCAATGACAAAGGTAC CCTGGAAGGGCTCGCCCTCTGCGGAATTTCAGTTCATGCAGGCCTTGGTGCTTCCACATCTGTCCAAGGGCCTTTCAAATGTGACTTTTAACTCTGTGGATTGATTTGCCCGG
Pharmacophore and FTrees
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Cédric Notredame (30/08/2015) Chemoinformatics And Bioinformatics Cédric Notredame Molecular Biology Bioinformatics Chemoinformatics Chemistry.
Molecular Descriptors
Functional groups / Pharmacological Activity
Asia’s Largest Global Software & Services Company Genomes to Drugs: A Bioinformatics Perspective Sharmila Mande Bioinformatics Division Advanced Technology.
1 Total size of the pipeline Citeline annual review 2012 ?? Adverse drug reactions (ADMET) Can Ayurvedic Treatment Help in Integrating with Modern.
Stereochemistry & Chiral Molecules. Isomerism Isomers are different compounds with the same molecular formula 1) Constitutional isomers: their atoms are.
Daniel Brown. D9.1 Discuss the use of a compound library in drug design. Traditionally, a large collection of related compounds are synthesized individually.
Faculté de Chimie, ULP, Strasbourg, FRANCE
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Drug Discovery Process Massimiliano Beltramo, PhD.
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
Ligand-based drug discovery No a priori knowledge of the receptor What information can we get from a few active compounds.
Amino Acids:. Peptide Bond 1.Considering only 26 symbols in the English alphabet, how come we can make so many words? 2.How is it possible to make.
1 Cheminformatics David Shiuan Department of Life Science and Institute of Biotechnology National Dong Hwa University.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 10 DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS Part 2: Section 10.2.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Alessandro Pedretti MetaPies, an annotated database for metabolism analysis and prediction: results and future perspectives L’Aquila November 21, 2011.
Proteomics Session 1 Introduction. Some basic concepts in biology and biochemistry.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Use of Machine Learning in Chemoinformatics
Identification of structurally diverse Growth Hormone Secretagogue (GHS) agonists by virtual screening and structure-activity relationship analysis of.
Molecular mechanics Classical physics, treats atoms as spheres Calculations are rapid, even for large molecules Useful for studying conformations Cannot.
Shows tendency for mergers. These big companies may be shrinking – much research is now outsourced to low cost countries like Latvia, India, China and.
Molecular Modeling in Drug Discovery: an Overview
Advantages of Good Drug-like Properties 손한표.
Julia Salas CS379a Aim of the Study To determine distinguishing features of orally administered drugs –Physical and structural features probed.
SMA5422: Special Topics in Biotechnology Lecture 11: Computer aided drug design: QSAR approach. SMA5422: Special Topics in Biotechnology Lecture 11: Computer.
Natural products from plants
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Lipinski’s rule of five
Homology Modeling and Docking to Potential Novel Inhibitor for
Simplified picture of the principles used for multiple copy simultaneous search (MCSS) and for computational combinatorial ligand design (CCLD). Simplified.
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Important Points in Drug Design based on Bioinformatics Tools
Virtual Screening.
Amino Acids An amino acid is any compound that contains an amino group (—NH2) and a carboxyl group (—COOH) in the same molecule.
Important Points in Drug Design based on Bioinformatics Tools
Cheminformatics Basics
ORGANIC PHARMACEUTICAL CHEMISTRY IV
Patrick: An Introduction to Medicinal Chemistry 6e
Presentation transcript:

Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course

2CBS, Department of Systems Biology Drug Discovery Process Disease Drug target Drug candidate Animal studies Clinical studies Marketed drug

3CBS, Department of Systems Biology The drug candidate ... is a (ligand) compound that binds to a biological target (protein, enzyme, receptor,...) and in this way either initiates a process (agonist) or inhibits it (antagonist/inhibitor)  The structure/conformation of the ligand is complementary to the space defined by the protein’s active site  The binding is caused by favorable interactions between the ligand and the side chains of the amino acids in the active site. (electrostatic interactions, hydrogen bonds, hydrophobic contacts...)

4CBS, Department of Systems Biology

5 Wet-lab drug discovery process Screening collection HTS Actives 10 3 actives10 6 cmp.

6CBS, Department of Systems Biology Screening collection HTS Actives 10 3 actives10 6 cmp. High rate of false actives!!! High throughput is not enough to get high output….. Wet-lab drug discovery process

7CBS, Department of Systems Biology Screening collection HTS Actives 10 3 actives10 6 cmp. Follow-up Chemical structure Purity Mechanism Activity value Wet-lab drug discovery process

8CBS, Department of Systems Biology Screening collection HTS Actives 10 3 actives10 6 cmp. Follow-up Hits 1-10 hits Analogues synthesis and testing ADMET properties Wet-lab drug discovery process

9CBS, Department of Systems Biology Wet-lab drug discovery process Screening collection HTS Actives 10 3 actives10 6 cmp. Follow-up Hits 1-10 hits Lead series 0-3 lead series Hit-to-lead Analogues synthesis and testing ADMET properties

10CBS, Department of Systems Biology Wet-lab drug discovery process Screening collection HTS Actives 10 3 actives10 6 cmp. Follow-up Hits 1-10 hits Lead series 0-3 lead series Hit-to-lead Drug candidate 0-1 Lead-to-drug Analogues synthesis and testing ADMET properties

11CBS, Department of Systems Biology

12CBS, Department of Systems Biology Failures

13CBS, Department of Systems Biology We need more.. to find less..

14CBS, Department of Systems Biology Drug Discovery Process Disease Drug target Drug candidate Animal studies Clinical studies Marketed drug Chemoinformatics

15CBS, Department of Systems Biology Wet-lab + Dry-lab drug discovery Diverse set of molecules tested in the lab in vitro in silico + in vitro Computational methods to select subsets (to be tested in the lab) based on prediction of drug-likeness, solubility, binding, pharmacokinetics, toxicity, side effects,...

16CBS, Department of Systems Biology The Lipinski ‘rule of five’ for drug- likeness prediction  Molecular weight ≤ 500  # hydrogen bond acceptors (HBA) ≤ 10  # hydrogen bond donors (HBD) ≤ 5  Octanol-water partition coefficient (logP) ≤ 5 (MlogP ≤ 4.15) If two or more of these rules are violated, the compound might have problems with oral bioavailability. (Lipinski et al., Adv. Drug Delivery Rev., 23, 1997, 3.)

17CBS, Department of Systems Biology Exercise : Prediction of drug-likeness Go to the following webpage Draw proguanil and decide if it is a drug- like compound

18CBS, Department of Systems Biology

19CBS, Department of Systems Biology Proguanil antimalarian tablets

20CBS, Department of Systems Biology Chemoinformatics Gathering and systematic use of chemical information, and application of this information to predict the behavior of unknown compounds in silico. dataprediction

21CBS, Department of Systems Biology Major Aspects of Chemoinformatics Databases: Development of databases for storage and retrieval of small molecule structures and their properties. Machine learning: Training of Decision Trees, Neural Networks, Self Organizing Maps, etc. on molecular data. Predictions: Molecular properties relevant to drugs, virtual screening of chemical libraries, system chemical biology networks…

22CBS, Department of Systems Biology

23CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms C 8 H 9 NO 3

24CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

25CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types (aromatic ring identification) –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

26CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

27CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

28CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

29CBS, Department of Systems Biology Representing a chemical structure How much information do you want to include? –atoms present –connections between atoms bond types –stereochemical configuration –charges –isotopes –3D-coordinates for atoms

30CBS, Department of Systems Biology From chemists to representations

31CBS, Department of Systems Biology Structural representation of molecules Line notations Connection tables

32CBS, Department of Systems Biology SMILES (Simplified Molecular Input Line Entry System) Canonical SMILES: unique for each structure Isomeric SMILES: describe isotopism, configuration around double bonds and tetrahedral centers, chirality

33CBS, Department of Systems Biology InChI (IUPAC International Chemical Identifier)

34CBS, Department of Systems Biology MOLfile format (.sdf)

35CBS, Department of Systems Biology Small molecule databases

36CBS, Department of Systems Biology Try it yourself! Go to PubChem: pubchem.ncbi.nlm.nih.gov/ Type proguanil and press Go Click on the first result on the list

37CBS, Department of Systems Biology Try it yourself! Scroll down and find the SMILES and InChI

38CBS, Department of Systems Biology Try it yourself! Click on SDF (top right icon) Select: 2D SDF: Display

39CBS, Department of Systems Biology Try it yourself! Go back and click again on SDF Select: 3D SDF: Display

40CBS, Department of Systems Biology Questions?